LAVA THERAPEUTICS NV (LVTX) Stock Analyst Ratings
USA - NASDAQ:LVTX - NL0015000AG6 - Common Stock
1.65 USD
-0.05 (-2.94%)
ChartMill assigns a Buy % Consensus number of 46% to LVTX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 1.4. This target is -15.31% below the current price.
LVTX was analyzed by 7 analysts. The buy percentage consensus is at 46. So analysts seem to be rather neutral about LVTX.
In the previous month the buy percentage consensus was at a similar level.
LVTX was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-05 | Jefferies | Downgrade | Buy -> Hold |
| 2025-08-05 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2025-05-15 | JMP Securities | Reiterate | Market Perform -> Market Perform |
| 2025-03-31 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2025-02-27 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2024-12-20 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-12-12 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2024-12-11 | JMP Securities | Downgrade | Market Outperform -> Market Perform |
| 2024-08-21 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-06-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-11-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-23 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2023-08-23 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-06-15 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2023-06-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-09 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2023-04-13 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-02-17 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-10-25 | HC Wainwright & Co. | Initiate | Buy |
| 2022-09-27 | SVB Leerink | Maintains | Outperform |
| 2022-09-15 | JMP Securities | Initiate | Market Outperform |
| 2022-05-18 | SVB Leerink | Maintains | Outperform |
| 2021-11-16 | SVB Leerink | Maintains | Outperform |
| 2021-08-17 | SVB Leerink | Maintains | Outperform |
| 2021-04-19 | SVB Leerink | Initiate | Outperform |
| 2021-04-19 | JP Morgan | Initiate | Overweight |
| 2021-04-19 | Jefferies | Initiate | Buy |
LAVA THERAPEUTICS NV / LVTX FAQ
What is the price target for LVTX stock?
7 analysts have analysed LVTX and the average price target is 1.4 USD. This implies a price decrease of -15.31% is expected in the next year compared to the current price of 1.65.
What is the consensus rating for LAVA THERAPEUTICS NV (LVTX) stock?
The consensus rating for LAVA THERAPEUTICS NV (LVTX) is 45.7143 / 100 . This indicates that analysts generally have a neutral outlook on the stock.